Alimta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Condition:   Mesothelioma Interventions:   Drug: Durvalumab / tremelimumab;   Drug: Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab Sponsors:   Baylor College of Medicine;   Duke Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials